Role of apoptosis for mouse liver growth regulation and tumor promotion: comparative analysis of mice with high (C3H/He) and low (C57Bl/6J) cancer susceptibility

被引:20
作者
Bursch, W
Grasl-Kraupp, B
Wastl, U
Hufnagl, K
Chabicovsky, M
Taper, H
Schulte-Hermann, R
机构
[1] Med Univ Vienna, Inst Canc Res, A-1090 Vienna, Austria
[2] Igeneon Immunotherapy Canc AG, A-1230 Vienna, Austria
[3] Univ Catholique Louvain, Unite Biochem Toxicol & Cancerol, B-1200 Brussels, Belgium
关键词
C3H/He; C57BL/6J; heptocarcinogenesis; tumor susceptibility; apoptosis; cell proliferation;
D O I
10.1016/j.toxlet.2003.12.018
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 [卫生毒理学];
摘要
Apoptosis constitutes one of the organisms defense lines against cancer. We investigated whether failure of apoptosis may be concurrently causative for the high cancer Susceptibility in C3H/He as compared to C57BL/6J mice (low cancer susceptibility). First, in short-term in vivo experiments (7-21 days), mouse liver growth (C3H/He, C57BL/6J) was induced by administration of phenobarbital (PB; 2 days 500 ppm + 5 days 750 ppm via the food) or nafenopin (NAF; 7 days 500 ppm via the food), cessation of PB or NAF treatment served to initiate liver involution. Liver weight, DNA content, hepatocyte ploidy and apoptotic activity were studied as endpoints. Secondly, in a long-term study liver carcinogenesis was initiated by a single dose of N-nitrosodiethylamine (NDEA, 90 mg/kg b.w.) to 5-weeks-old C57B1/6J and C3H/He mice. After 2 weeks, mice received either standard diet or a diet containing phenobarbital (PB, 90 mg/kg b.w.) for up to 90 weeks. Cell proliferation and apoptosis in normal liver tissue and (pre)neoplastic tissue was quantitatively analysed by histological means. The short term studies revealed that PB and NAF-induced mouse liver growth is essentially due to cell enlargement (hypertrophy). A moderate increase of liver DNA content was brought about by hepatocellular polyploidization; C3H/He mice exhibited the most pronounced ploidy shift, corresponding to their high cancer susceptibility. Upon cessation of PB or NAF treatment, regression of liver mass was neither associated with a loss of DNA nor an increase in apoptoses in the liver of C3H/He and C57B1/6J mice; food restriction did not enforce the occurrence of apoptosis. Thus, the mouse strains did not differ with respect to the occurrence of apoptosis. In the long-term study, PB promoted liver tumor formation in all strains, exhibiting quantitative differences in growth kinetics of preneoplasia rather than a specific biological quality. Quantitative analysis of apoptosis in normal and (pre)neoplastic liver tissue of C3H/He and C57BL/6J mice revealed no clue to explain their different cancer susceptibility. Rather, cell proliferation seems to be the prevailing determinant of tumor promotion in the liver of both mouse strains. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:25 / 35
页数:11
相关论文
共 52 条
[1]
Safety assessment for non-genotoxic rodent carcinogens: curves, low-dose extrapolations, and mechanisms in carcinogenesis [J].
Alden, CL .
HUMAN & EXPERIMENTAL TOXICOLOGY, 2000, 19 (10) :557-560
[2]
BANNASCH P, 1994, PATHOLOGY NEOPLASIA
[3]
CONTROLLED DEATH (APOPTOSIS) OF NORMAL AND PUTATIVE PRENEOPLASTIC CELLS IN RAT-LIVER FOLLOWING WITHDRAWAL OF TUMOR PROMOTERS [J].
BURSCH, W ;
LAUER, B ;
TIMMERMANNTROSIENER, I ;
BARTHEL, G ;
SCHUPPLER, J ;
SCHULTEHERMANN, R .
CARCINOGENESIS, 1984, 5 (04) :453-458
[4]
BURSCH W, 1983, CELL TISSUE KINET, V16, P125
[5]
BURSCH W, 1992, TISSUE SPECIFIC TOXI, P95
[6]
Biochemical, pathologic and morphometric alterations induced in male B6C3F1 mouse liver by short-term exposure to dichloroacetic acid [J].
Carter, JH ;
Carter, HW ;
DeAngelo, AB .
TOXICOLOGY LETTERS, 1995, 81 (01) :55-71
[7]
CARTER JH, 2003, HLTH PERSPECT, V11, P53
[8]
Induction of apoptosis in mouse liver adenoma and carcinoma in vivo by transforming growth factor-β1 [J].
Chabicovsky, M ;
Wastl, U ;
Taper, H ;
Grasl-Kraupp, B ;
Schulte-Hermann, R ;
Bursch, W .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2003, 129 (09) :536-542
[9]
Christensen JG, 1999, MOL CARCINOGEN, V25, P273
[10]
DIWAN BA, 1987, TOXICOLOGIST, V7, P106